nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCC4—Conjugated Estrogens—osteoporosis	0.0416	0.157	CbGbCtD
Sunitinib—ABCC2—Ethinyl Estradiol—osteoporosis	0.0337	0.127	CbGbCtD
Sunitinib—ABCC2—Conjugated Estrogens—osteoporosis	0.0247	0.0936	CbGbCtD
Sunitinib—ABCG2—Conjugated Estrogens—osteoporosis	0.0224	0.0846	CbGbCtD
Sunitinib—ABCG2—Estradiol—osteoporosis	0.0196	0.0743	CbGbCtD
Sunitinib—CYP3A7—Estradiol—osteoporosis	0.0145	0.0549	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0145	0.0549	CbGbCtD
Sunitinib—ABCB1—Ethinyl Estradiol—osteoporosis	0.011	0.0416	CbGbCtD
Sunitinib—CYP3A5—Estradiol—osteoporosis	0.0109	0.0412	CbGbCtD
Sunitinib—CYP3A4—Estropipate—osteoporosis	0.0102	0.0386	CbGbCtD
Sunitinib—CYP3A4—Calcitriol—osteoporosis	0.0102	0.0386	CbGbCtD
Sunitinib—CYP3A4—Ergocalciferol—osteoporosis	0.00817	0.0309	CbGbCtD
Sunitinib—ABCB1—Conjugated Estrogens—osteoporosis	0.00806	0.0305	CbGbCtD
Sunitinib—ABCB1—Estradiol—osteoporosis	0.00708	0.0268	CbGbCtD
Sunitinib—CYP3A4—Raloxifene—osteoporosis	0.00682	0.0258	CbGbCtD
Sunitinib—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00658	0.0249	CbGbCtD
Sunitinib—CYP3A4—Cholecalciferol—osteoporosis	0.00526	0.0199	CbGbCtD
Sunitinib—CYP3A4—Conjugated Estrogens—osteoporosis	0.00483	0.0183	CbGbCtD
Sunitinib—CYP3A4—Estradiol—osteoporosis	0.00424	0.016	CbGbCtD
Sunitinib—RET—parathyroid gland—osteoporosis	0.00391	0.0356	CbGeAlD
Sunitinib—FGFR2—skull—osteoporosis	0.0038	0.0347	CbGeAlD
Sunitinib—CSF1R—periosteum—osteoporosis	0.00354	0.0323	CbGeAlD
Sunitinib—CDK14—uterus—osteoporosis	0.00146	0.0133	CbGeAlD
Sunitinib—STK33—uterus—osteoporosis	0.00142	0.0129	CbGeAlD
Sunitinib—RPS6KA5—uterus—osteoporosis	0.00142	0.0129	CbGeAlD
Sunitinib—CLK4—uterus—osteoporosis	0.00136	0.0124	CbGeAlD
Sunitinib—STK17B—bone marrow—osteoporosis	0.00136	0.0124	CbGeAlD
Sunitinib—BRD4—uterus—osteoporosis	0.00127	0.0116	CbGeAlD
Sunitinib—STK11—uterus—osteoporosis	0.00127	0.0116	CbGeAlD
Sunitinib—RPS6KA1—uterus—osteoporosis	0.00126	0.0115	CbGeAlD
Sunitinib—STK17A—bone marrow—osteoporosis	0.00125	0.0114	CbGeAlD
Sunitinib—SGK3—uterus—osteoporosis	0.00123	0.0112	CbGeAlD
Sunitinib—ICK—uterus—osteoporosis	0.00121	0.0111	CbGeAlD
Sunitinib—RPS6KA5—bone marrow—osteoporosis	0.0012	0.011	CbGeAlD
Sunitinib—NUAK1—uterus—osteoporosis	0.00117	0.0107	CbGeAlD
Sunitinib—SNRK—uterus—osteoporosis	0.00116	0.0106	CbGeAlD
Sunitinib—OXSR1—uterus—osteoporosis	0.00116	0.0106	CbGeAlD
Sunitinib—INSR—uterus—osteoporosis	0.00116	0.0106	CbGeAlD
Sunitinib—CLK4—bone marrow—osteoporosis	0.00116	0.0106	CbGeAlD
Sunitinib—RPS6KA2—uterus—osteoporosis	0.00114	0.0104	CbGeAlD
Sunitinib—STK38—uterus—osteoporosis	0.00114	0.0104	CbGeAlD
Sunitinib—ITK—bone marrow—osteoporosis	0.00114	0.0104	CbGeAlD
Sunitinib—PKN1—uterus—osteoporosis	0.00113	0.0103	CbGeAlD
Sunitinib—PRPF4B—uterus—osteoporosis	0.00109	0.00999	CbGeAlD
Sunitinib—BRD4—bone marrow—osteoporosis	0.00108	0.00987	CbGeAlD
Sunitinib—STK11—bone marrow—osteoporosis	0.00108	0.00987	CbGeAlD
Sunitinib—STK39—uterus—osteoporosis	0.00108	0.00985	CbGeAlD
Sunitinib—RPS6KA1—bone marrow—osteoporosis	0.00107	0.00977	CbGeAlD
Sunitinib—RIOK1—bone marrow—osteoporosis	0.00107	0.00977	CbGeAlD
Sunitinib—CSNK2A1—uterus—osteoporosis	0.00107	0.00972	CbGeAlD
Sunitinib—MYLK—uterus—osteoporosis	0.00105	0.0096	CbGeAlD
Sunitinib—SGK3—bone marrow—osteoporosis	0.00104	0.00949	CbGeAlD
Sunitinib—ICK—bone marrow—osteoporosis	0.00103	0.0094	CbGeAlD
Sunitinib—STK24—uterus—osteoporosis	0.00101	0.0092	CbGeAlD
Sunitinib—CHEK2—bone marrow—osteoporosis	0.000995	0.00908	CbGeAlD
Sunitinib—SNRK—bone marrow—osteoporosis	0.000987	0.00901	CbGeAlD
Sunitinib—OXSR1—bone marrow—osteoporosis	0.000987	0.00901	CbGeAlD
Sunitinib—STK38—bone marrow—osteoporosis	0.000972	0.00886	CbGeAlD
Sunitinib—RPS6KA2—bone marrow—osteoporosis	0.000972	0.00886	CbGeAlD
Sunitinib—TNK1—uterus—osteoporosis	0.000966	0.00881	CbGeAlD
Sunitinib—CSNK1G2—bone marrow—osteoporosis	0.000957	0.00873	CbGeAlD
Sunitinib—PKN1—bone marrow—osteoporosis	0.000957	0.00873	CbGeAlD
Sunitinib—PRPF4—bone marrow—osteoporosis	0.000943	0.0086	CbGeAlD
Sunitinib—DAPK3—uterus—osteoporosis	0.000938	0.00855	CbGeAlD
Sunitinib—PRPF4B—bone marrow—osteoporosis	0.000929	0.00848	CbGeAlD
Sunitinib—MAP4K2—uterus—osteoporosis	0.000925	0.00844	CbGeAlD
Sunitinib—STK39—bone marrow—osteoporosis	0.000917	0.00836	CbGeAlD
Sunitinib—STK3—uterus—osteoporosis	0.000912	0.00832	CbGeAlD
Sunitinib—CSNK2A1—bone marrow—osteoporosis	0.000904	0.00825	CbGeAlD
Sunitinib—PLK4—bone marrow—osteoporosis	0.000882	0.00804	CbGeAlD
Sunitinib—STK24—bone marrow—osteoporosis	0.000856	0.00781	CbGeAlD
Sunitinib—DAPK2—bone marrow—osteoporosis	0.000846	0.00772	CbGeAlD
Sunitinib—MAP4K4—uterus—osteoporosis	0.000842	0.00768	CbGeAlD
Sunitinib—HIPK3—bone marrow—osteoporosis	0.000828	0.00756	CbGeAlD
Sunitinib—RIOK2—bone marrow—osteoporosis	0.00082	0.00748	CbGeAlD
Sunitinib—RPS6KA3—uterus—osteoporosis	0.000818	0.00747	CbGeAlD
Sunitinib—MAP4K1—bone marrow—osteoporosis	0.000811	0.0074	CbGeAlD
Sunitinib—CSNK1A1—uterus—osteoporosis	0.000802	0.00732	CbGeAlD
Sunitinib—CLK1—uterus—osteoporosis	0.000797	0.00727	CbGeAlD
Sunitinib—CLK2—bone marrow—osteoporosis	0.000788	0.00719	CbGeAlD
Sunitinib—MAP4K2—bone marrow—osteoporosis	0.000785	0.00716	CbGeAlD
Sunitinib—PRPF4—Calcitriol—Ergocalciferol—osteoporosis	0.000784	0.143	CbGdCrCtD
Sunitinib—CAMK2G—uterus—osteoporosis	0.000783	0.00714	CbGeAlD
Sunitinib—CSNK1E—uterus—osteoporosis	0.000744	0.00678	CbGeAlD
Sunitinib—FGFR1—uterus—osteoporosis	0.000744	0.00678	CbGeAlD
Sunitinib—MERTK—bone marrow—osteoporosis	0.000728	0.00664	CbGeAlD
Sunitinib—ULK3—uterus—osteoporosis	0.000716	0.00653	CbGeAlD
Sunitinib—MAP2K2—uterus—osteoporosis	0.000716	0.00653	CbGeAlD
Sunitinib—MAP4K4—bone marrow—osteoporosis	0.000714	0.00652	CbGeAlD
Sunitinib—MAP3K2—uterus—osteoporosis	0.000711	0.00648	CbGeAlD
Sunitinib—NUAK2—bone marrow—osteoporosis	0.000709	0.00647	CbGeAlD
Sunitinib—FLT3—bone marrow—osteoporosis	0.000704	0.00643	CbGeAlD
Sunitinib—MAP3K7—uterus—osteoporosis	0.000704	0.00642	CbGeAlD
Sunitinib—RPS6KA3—bone marrow—osteoporosis	0.000695	0.00634	CbGeAlD
Sunitinib—TYK2—uterus—osteoporosis	0.000691	0.00631	CbGeAlD
Sunitinib—MAP2K1—bone marrow—osteoporosis	0.00069	0.0063	CbGeAlD
Sunitinib—CSNK1A1—bone marrow—osteoporosis	0.000681	0.00621	CbGeAlD
Sunitinib—CLK1—bone marrow—osteoporosis	0.000677	0.00617	CbGeAlD
Sunitinib—PRPF4—Calcitriol—Cholecalciferol—osteoporosis	0.000666	0.121	CbGdCrCtD
Sunitinib—BMP2K—bone marrow—osteoporosis	0.000664	0.00606	CbGeAlD
Sunitinib—CAMK2G—bone marrow—osteoporosis	0.000664	0.00606	CbGeAlD
Sunitinib—AXL—uterus—osteoporosis	0.000663	0.00605	CbGeAlD
Sunitinib—LRRK2—bone marrow—osteoporosis	0.000658	0.00601	CbGeAlD
Sunitinib—PRKAA1—bone marrow—osteoporosis	0.000649	0.00592	CbGeAlD
Sunitinib—PTK2B—bone marrow—osteoporosis	0.000641	0.00585	CbGeAlD
Sunitinib—FLT4—bone marrow—osteoporosis	0.00064	0.00584	CbGeAlD
Sunitinib—SLK—uterus—osteoporosis	0.000638	0.00582	CbGeAlD
Sunitinib—FGFR2—uterus—osteoporosis	0.000632	0.00577	CbGeAlD
Sunitinib—IRAK4—bone marrow—osteoporosis	0.000621	0.00567	CbGeAlD
Sunitinib—FYN—uterus—osteoporosis	0.00062	0.00566	CbGeAlD
Sunitinib—TLK2—Levorphanol—Estradiol—osteoporosis	0.000611	0.111	CbGdCrCtD
Sunitinib—MAP2K2—bone marrow—osteoporosis	0.000607	0.00554	CbGeAlD
Sunitinib—ULK3—bone marrow—osteoporosis	0.000607	0.00554	CbGeAlD
Sunitinib—MAP4K5—uterus—osteoporosis	0.000606	0.00553	CbGeAlD
Sunitinib—MAP3K2—bone marrow—osteoporosis	0.000603	0.0055	CbGeAlD
Sunitinib—MAP3K7—bone marrow—osteoporosis	0.000597	0.00545	CbGeAlD
Sunitinib—FGFR2—Estradiol—Estropipate—osteoporosis	0.000593	0.108	CbGdCrCtD
Sunitinib—TBK1—bone marrow—osteoporosis	0.000591	0.00539	CbGeAlD
Sunitinib—TYK2—bone marrow—osteoporosis	0.000587	0.00535	CbGeAlD
Sunitinib—FLT1—uterus—osteoporosis	0.000586	0.00535	CbGeAlD
Sunitinib—IRAK1—bone marrow—osteoporosis	0.000579	0.00528	CbGeAlD
Sunitinib—RPS6KB1—bone marrow—osteoporosis	0.000568	0.00518	CbGeAlD
Sunitinib—FGR—bone marrow—osteoporosis	0.000565	0.00515	CbGeAlD
Sunitinib—YES1—uterus—osteoporosis	0.00056	0.00511	CbGeAlD
Sunitinib—STK10—uterus—osteoporosis	0.000555	0.00506	CbGeAlD
Sunitinib—TAOK3—uterus—osteoporosis	0.000553	0.00504	CbGeAlD
Sunitinib—PDGFRA—uterus—osteoporosis	0.000549	0.00501	CbGeAlD
Sunitinib—SLK—bone marrow—osteoporosis	0.000541	0.00494	CbGeAlD
Sunitinib—JAK2—bone marrow—osteoporosis	0.000534	0.00487	CbGeAlD
Sunitinib—FYN—bone marrow—osteoporosis	0.000526	0.0048	CbGeAlD
Sunitinib—MAP4K5—bone marrow—osteoporosis	0.000514	0.00469	CbGeAlD
Sunitinib—MAP3K3—bone marrow—osteoporosis	0.000514	0.00469	CbGeAlD
Sunitinib—KDR—uterus—osteoporosis	0.000495	0.00452	CbGeAlD
Sunitinib—CSF1R—uterus—osteoporosis	0.000483	0.00441	CbGeAlD
Sunitinib—YES1—bone marrow—osteoporosis	0.000475	0.00433	CbGeAlD
Sunitinib—STK10—bone marrow—osteoporosis	0.000471	0.0043	CbGeAlD
Sunitinib—TAOK3—bone marrow—osteoporosis	0.000469	0.00428	CbGeAlD
Sunitinib—FGFR2—Estradiol—Conjugated Estrogens—osteoporosis	0.000449	0.0819	CbGdCrCtD
Sunitinib—KIT—uterus—osteoporosis	0.000439	0.00401	CbGeAlD
Sunitinib—PRPF4—Fulvestrant—Estradiol—osteoporosis	0.000437	0.0797	CbGdCrCtD
Sunitinib—PDGFRB—uterus—osteoporosis	0.000429	0.00391	CbGeAlD
Sunitinib—KDR—bone marrow—osteoporosis	0.00042	0.00384	CbGeAlD
Sunitinib—CSF1R—bone marrow—osteoporosis	0.00041	0.00374	CbGeAlD
Sunitinib—FGFR2—Estradiol—Ethinyl Estradiol—osteoporosis	0.000377	0.0688	CbGdCrCtD
Sunitinib—KIT—bone marrow—osteoporosis	0.000373	0.0034	CbGeAlD
Sunitinib—PDGFRB—bone marrow—osteoporosis	0.000364	0.00332	CbGeAlD
Sunitinib—PLK4—Fulvestrant—Estradiol—osteoporosis	0.000346	0.0631	CbGdCrCtD
Sunitinib—ABCC4—uterus—osteoporosis	0.000341	0.00311	CbGeAlD
Sunitinib—CHEK2—Fulvestrant—Estradiol—osteoporosis	0.000305	0.0556	CbGdCrCtD
Sunitinib—ABCC4—bone marrow—osteoporosis	0.00029	0.00264	CbGeAlD
Sunitinib—KCNH2—uterus—osteoporosis	0.000271	0.00247	CbGeAlD
Sunitinib—CSNK1E—Danazol—Ethinyl Estradiol—osteoporosis	0.00026	0.0474	CbGdCrCtD
Sunitinib—ABCG2—uterus—osteoporosis	0.000241	0.0022	CbGeAlD
Sunitinib—KCNH2—bone marrow—osteoporosis	0.00023	0.0021	CbGeAlD
Sunitinib—ABCG2—bone marrow—osteoporosis	0.000205	0.00187	CbGeAlD
Sunitinib—PRPF4—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000172	0.0314	CbGdCrCtD
Sunitinib—Hepatitis—Estradiol—osteoporosis	0.00014	0.000465	CcSEcCtD
Sunitinib—Abdominal pain—Calcitriol—osteoporosis	0.000139	0.000464	CcSEcCtD
Sunitinib—Body temperature increased—Calcitriol—osteoporosis	0.000139	0.000464	CcSEcCtD
Sunitinib—Hypoaesthesia—Estradiol—osteoporosis	0.000139	0.000463	CcSEcCtD
Sunitinib—Angioedema—Conjugated Estrogens—osteoporosis	0.000139	0.000462	CcSEcCtD
Sunitinib—Shock—Pamidronate—osteoporosis	0.000139	0.000462	CcSEcCtD
Sunitinib—Hypersensitivity—Estropipate—osteoporosis	0.000138	0.00046	CcSEcCtD
Sunitinib—Nervous system disorder—Pamidronate—osteoporosis	0.000138	0.00046	CcSEcCtD
Sunitinib—Thrombocytopenia—Pamidronate—osteoporosis	0.000138	0.00046	CcSEcCtD
Sunitinib—Urinary tract disorder—Estradiol—osteoporosis	0.000138	0.000459	CcSEcCtD
Sunitinib—Vomiting—Etidronic acid—osteoporosis	0.000138	0.000459	CcSEcCtD
Sunitinib—Cough—Zoledronate—osteoporosis	0.000138	0.000458	CcSEcCtD
Sunitinib—Oedema peripheral—Estradiol—osteoporosis	0.000138	0.000458	CcSEcCtD
Sunitinib—Connective tissue disorder—Estradiol—osteoporosis	0.000137	0.000457	CcSEcCtD
Sunitinib—Urethral disorder—Estradiol—osteoporosis	0.000137	0.000456	CcSEcCtD
Sunitinib—PRPF4—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000137	0.025	CbGdCrCtD
Sunitinib—Rash—Etidronic acid—osteoporosis	0.000137	0.000455	CcSEcCtD
Sunitinib—Convulsion—Zoledronate—osteoporosis	0.000137	0.000455	CcSEcCtD
Sunitinib—Dermatitis—Etidronic acid—osteoporosis	0.000137	0.000455	CcSEcCtD
Sunitinib—Hypertension—Zoledronate—osteoporosis	0.000136	0.000454	CcSEcCtD
Sunitinib—Hypersensitivity—Alendronate—osteoporosis	0.000136	0.000453	CcSEcCtD
Sunitinib—Headache—Etidronic acid—osteoporosis	0.000136	0.000452	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000135	0.00045	CcSEcCtD
Sunitinib—Asthenia—Estropipate—osteoporosis	0.000135	0.000448	CcSEcCtD
Sunitinib—Anorexia—Pamidronate—osteoporosis	0.000134	0.000447	CcSEcCtD
Sunitinib—Arthralgia—Zoledronate—osteoporosis	0.000134	0.000447	CcSEcCtD
Sunitinib—Chest pain—Zoledronate—osteoporosis	0.000134	0.000447	CcSEcCtD
Sunitinib—Myalgia—Zoledronate—osteoporosis	0.000134	0.000447	CcSEcCtD
Sunitinib—Insomnia—Risedronate—osteoporosis	0.000134	0.000447	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000133	0.000444	CcSEcCtD
Sunitinib—CHEK2—Danazol—Ethinyl Estradiol—osteoporosis	0.000133	0.0243	CbGdCrCtD
Sunitinib—Paraesthesia—Risedronate—osteoporosis	0.000133	0.000443	CcSEcCtD
Sunitinib—Pruritus—Estropipate—osteoporosis	0.000133	0.000442	CcSEcCtD
Sunitinib—Asthenia—Alendronate—osteoporosis	0.000133	0.000442	CcSEcCtD
Sunitinib—Hypersensitivity—Ibandronate—osteoporosis	0.000133	0.000441	CcSEcCtD
Sunitinib—Cough—Conjugated Estrogens—osteoporosis	0.000133	0.000441	CcSEcCtD
Sunitinib—Dyspnoea—Risedronate—osteoporosis	0.000132	0.00044	CcSEcCtD
Sunitinib—Erythema multiforme—Estradiol—osteoporosis	0.000132	0.00044	CcSEcCtD
Sunitinib—Convulsion—Conjugated Estrogens—osteoporosis	0.000132	0.000438	CcSEcCtD
Sunitinib—Dry mouth—Zoledronate—osteoporosis	0.000131	0.000437	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000131	0.000437	CcSEcCtD
Sunitinib—Fatigue—Ethinyl Estradiol—osteoporosis	0.000131	0.000437	CcSEcCtD
Sunitinib—Pruritus—Alendronate—osteoporosis	0.000131	0.000435	CcSEcCtD
Sunitinib—Dyspepsia—Risedronate—osteoporosis	0.000131	0.000435	CcSEcCtD
Sunitinib—Eye disorder—Estradiol—osteoporosis	0.000131	0.000435	CcSEcCtD
Sunitinib—Constipation—Ethinyl Estradiol—osteoporosis	0.00013	0.000433	CcSEcCtD
Sunitinib—Hypersensitivity—Calcitriol—osteoporosis	0.00013	0.000432	CcSEcCtD
Sunitinib—Cardiac disorder—Estradiol—osteoporosis	0.00013	0.000432	CcSEcCtD
Sunitinib—Flushing—Estradiol—osteoporosis	0.00013	0.000432	CcSEcCtD
Sunitinib—Chest pain—Conjugated Estrogens—osteoporosis	0.000129	0.000431	CcSEcCtD
Sunitinib—Myalgia—Conjugated Estrogens—osteoporosis	0.000129	0.000431	CcSEcCtD
Sunitinib—Arthralgia—Conjugated Estrogens—osteoporosis	0.000129	0.000431	CcSEcCtD
Sunitinib—Asthenia—Ibandronate—osteoporosis	0.000129	0.00043	CcSEcCtD
Sunitinib—Nausea—Etidronic acid—osteoporosis	0.000129	0.000429	CcSEcCtD
Sunitinib—Oedema—Zoledronate—osteoporosis	0.000129	0.000429	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000128	0.000428	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000128	0.000428	CcSEcCtD
Sunitinib—Diarrhoea—Estropipate—osteoporosis	0.000128	0.000428	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Risedronate—osteoporosis	0.000128	0.000426	CcSEcCtD
Sunitinib—Infection—Zoledronate—osteoporosis	0.000128	0.000426	CcSEcCtD
Sunitinib—Fatigue—Risedronate—osteoporosis	0.000128	0.000426	CcSEcCtD
Sunitinib—Insomnia—Pamidronate—osteoporosis	0.000127	0.000425	CcSEcCtD
Sunitinib—Pruritus—Ibandronate—osteoporosis	0.000127	0.000424	CcSEcCtD
Sunitinib—Pain—Risedronate—osteoporosis	0.000127	0.000422	CcSEcCtD
Sunitinib—Constipation—Risedronate—osteoporosis	0.000127	0.000422	CcSEcCtD
Sunitinib—Angiopathy—Estradiol—osteoporosis	0.000127	0.000422	CcSEcCtD
Sunitinib—Shock—Zoledronate—osteoporosis	0.000127	0.000422	CcSEcCtD
Sunitinib—Paraesthesia—Pamidronate—osteoporosis	0.000127	0.000422	CcSEcCtD
Sunitinib—Diarrhoea—Alendronate—osteoporosis	0.000126	0.000421	CcSEcCtD
Sunitinib—Asthenia—Calcitriol—osteoporosis	0.000126	0.000421	CcSEcCtD
Sunitinib—Nervous system disorder—Zoledronate—osteoporosis	0.000126	0.00042	CcSEcCtD
Sunitinib—Immune system disorder—Estradiol—osteoporosis	0.000126	0.00042	CcSEcCtD
Sunitinib—Thrombocytopenia—Zoledronate—osteoporosis	0.000126	0.00042	CcSEcCtD
Sunitinib—Mediastinal disorder—Estradiol—osteoporosis	0.000126	0.000419	CcSEcCtD
Sunitinib—Dyspnoea—Pamidronate—osteoporosis	0.000126	0.000419	CcSEcCtD
Sunitinib—Chills—Estradiol—osteoporosis	0.000125	0.000417	CcSEcCtD
Sunitinib—Skin disorder—Zoledronate—osteoporosis	0.000125	0.000416	CcSEcCtD
Sunitinib—Pruritus—Calcitriol—osteoporosis	0.000125	0.000415	CcSEcCtD
Sunitinib—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000124	0.000414	CcSEcCtD
Sunitinib—Diarrhoea—Raloxifene—osteoporosis	0.000124	0.000414	CcSEcCtD
Sunitinib—Dyspepsia—Pamidronate—osteoporosis	0.000124	0.000413	CcSEcCtD
Sunitinib—Dizziness—Estropipate—osteoporosis	0.000124	0.000413	CcSEcCtD
Sunitinib—Oedema—Conjugated Estrogens—osteoporosis	0.000124	0.000413	CcSEcCtD
Sunitinib—Alopecia—Estradiol—osteoporosis	0.000123	0.000411	CcSEcCtD
Sunitinib—Infection—Conjugated Estrogens—osteoporosis	0.000123	0.00041	CcSEcCtD
Sunitinib—Diarrhoea—Ibandronate—osteoporosis	0.000123	0.00041	CcSEcCtD
Sunitinib—Anorexia—Zoledronate—osteoporosis	0.000123	0.000409	CcSEcCtD
Sunitinib—Decreased appetite—Pamidronate—osteoporosis	0.000123	0.000408	CcSEcCtD
Sunitinib—Mental disorder—Estradiol—osteoporosis	0.000122	0.000407	CcSEcCtD
Sunitinib—Dizziness—Alendronate—osteoporosis	0.000122	0.000407	CcSEcCtD
Sunitinib—Shock—Conjugated Estrogens—osteoporosis	0.000122	0.000406	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000122	0.000405	CcSEcCtD
Sunitinib—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000122	0.000405	CcSEcCtD
Sunitinib—Erythema—Estradiol—osteoporosis	0.000122	0.000405	CcSEcCtD
Sunitinib—Malnutrition—Estradiol—osteoporosis	0.000122	0.000405	CcSEcCtD
Sunitinib—Fatigue—Pamidronate—osteoporosis	0.000122	0.000405	CcSEcCtD
Sunitinib—Gastrointestinal pain—Risedronate—osteoporosis	0.000121	0.000404	CcSEcCtD
Sunitinib—Pain—Pamidronate—osteoporosis	0.000121	0.000401	CcSEcCtD
Sunitinib—Constipation—Pamidronate—osteoporosis	0.000121	0.000401	CcSEcCtD
Sunitinib—Diarrhoea—Calcitriol—osteoporosis	0.000121	0.000401	CcSEcCtD
Sunitinib—Skin disorder—Conjugated Estrogens—osteoporosis	0.00012	0.000401	CcSEcCtD
Sunitinib—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00012	0.0004	CcSEcCtD
Sunitinib—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00012	0.0004	CcSEcCtD
Sunitinib—Dizziness—Raloxifene—osteoporosis	0.00012	0.0004	CcSEcCtD
Sunitinib—CHEK2—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00012	0.0219	CbGdCrCtD
Sunitinib—Flatulence—Estradiol—osteoporosis	0.00012	0.000399	CcSEcCtD
Sunitinib—Vomiting—Estropipate—osteoporosis	0.000119	0.000397	CcSEcCtD
Sunitinib—Dysgeusia—Estradiol—osteoporosis	0.000119	0.000396	CcSEcCtD
Sunitinib—Dizziness—Ibandronate—osteoporosis	0.000119	0.000396	CcSEcCtD
Sunitinib—ABCB1—uterus—osteoporosis	0.000119	0.00108	CbGeAlD
Sunitinib—Rash—Estropipate—osteoporosis	0.000118	0.000394	CcSEcCtD
Sunitinib—Dermatitis—Estropipate—osteoporosis	0.000118	0.000394	CcSEcCtD
Sunitinib—Anorexia—Conjugated Estrogens—osteoporosis	0.000118	0.000394	CcSEcCtD
Sunitinib—Back pain—Estradiol—osteoporosis	0.000118	0.000392	CcSEcCtD
Sunitinib—Headache—Estropipate—osteoporosis	0.000118	0.000391	CcSEcCtD
Sunitinib—Vomiting—Alendronate—osteoporosis	0.000118	0.000391	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000117	0.000391	CcSEcCtD
Sunitinib—Abdominal pain—Risedronate—osteoporosis	0.000117	0.00039	CcSEcCtD
Sunitinib—Body temperature increased—Risedronate—osteoporosis	0.000117	0.00039	CcSEcCtD
Sunitinib—Muscle spasms—Estradiol—osteoporosis	0.000117	0.000389	CcSEcCtD
Sunitinib—Rash—Alendronate—osteoporosis	0.000117	0.000388	CcSEcCtD
Sunitinib—Insomnia—Zoledronate—osteoporosis	0.000116	0.000388	CcSEcCtD
Sunitinib—Dermatitis—Alendronate—osteoporosis	0.000116	0.000388	CcSEcCtD
Sunitinib—Headache—Alendronate—osteoporosis	0.000116	0.000386	CcSEcCtD
Sunitinib—Paraesthesia—Zoledronate—osteoporosis	0.000116	0.000385	CcSEcCtD
Sunitinib—Vomiting—Raloxifene—osteoporosis	0.000116	0.000385	CcSEcCtD
Sunitinib—Gastrointestinal pain—Pamidronate—osteoporosis	0.000115	0.000384	CcSEcCtD
Sunitinib—Dyspnoea—Zoledronate—osteoporosis	0.000115	0.000382	CcSEcCtD
Sunitinib—Rash—Raloxifene—osteoporosis	0.000115	0.000382	CcSEcCtD
Sunitinib—Dermatitis—Raloxifene—osteoporosis	0.000114	0.000381	CcSEcCtD
Sunitinib—Vomiting—Ibandronate—osteoporosis	0.000114	0.000381	CcSEcCtD
Sunitinib—Headache—Raloxifene—osteoporosis	0.000114	0.000379	CcSEcCtD
Sunitinib—Rash—Ibandronate—osteoporosis	0.000113	0.000378	CcSEcCtD
Sunitinib—Dermatitis—Ibandronate—osteoporosis	0.000113	0.000377	CcSEcCtD
Sunitinib—Dyspepsia—Zoledronate—osteoporosis	0.000113	0.000377	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000113	0.000376	CcSEcCtD
Sunitinib—Headache—Ibandronate—osteoporosis	0.000113	0.000375	CcSEcCtD
Sunitinib—Insomnia—Conjugated Estrogens—osteoporosis	0.000112	0.000373	CcSEcCtD
Sunitinib—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000112	0.000373	CcSEcCtD
Sunitinib—Vomiting—Calcitriol—osteoporosis	0.000112	0.000373	CcSEcCtD
Sunitinib—Decreased appetite—Zoledronate—osteoporosis	0.000112	0.000373	CcSEcCtD
Sunitinib—Nausea—Estropipate—osteoporosis	0.000111	0.000371	CcSEcCtD
Sunitinib—Abdominal pain—Pamidronate—osteoporosis	0.000111	0.000371	CcSEcCtD
Sunitinib—Body temperature increased—Pamidronate—osteoporosis	0.000111	0.000371	CcSEcCtD
Sunitinib—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000111	0.000371	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000111	0.00037	CcSEcCtD
Sunitinib—Angioedema—Estradiol—osteoporosis	0.000111	0.00037	CcSEcCtD
Sunitinib—Rash—Calcitriol—osteoporosis	0.000111	0.00037	CcSEcCtD
Sunitinib—Fatigue—Zoledronate—osteoporosis	0.000111	0.00037	CcSEcCtD
Sunitinib—Dermatitis—Calcitriol—osteoporosis	0.000111	0.000369	CcSEcCtD
Sunitinib—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000111	0.000368	CcSEcCtD
Sunitinib—Headache—Calcitriol—osteoporosis	0.00011	0.000367	CcSEcCtD
Sunitinib—Pain—Zoledronate—osteoporosis	0.00011	0.000367	CcSEcCtD
Sunitinib—Constipation—Zoledronate—osteoporosis	0.00011	0.000367	CcSEcCtD
Sunitinib—Nausea—Alendronate—osteoporosis	0.00011	0.000366	CcSEcCtD
Sunitinib—Hypersensitivity—Risedronate—osteoporosis	0.000109	0.000364	CcSEcCtD
Sunitinib—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000109	0.000363	CcSEcCtD
Sunitinib—Asthenia—Ethinyl Estradiol—osteoporosis	0.000109	0.000363	CcSEcCtD
Sunitinib—Nausea—Raloxifene—osteoporosis	0.000108	0.00036	CcSEcCtD
Sunitinib—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000108	0.000359	CcSEcCtD
Sunitinib—Pruritus—Ethinyl Estradiol—osteoporosis	0.000108	0.000358	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000107	0.000356	CcSEcCtD
Sunitinib—Fatigue—Conjugated Estrogens—osteoporosis	0.000107	0.000356	CcSEcCtD
Sunitinib—Nausea—Ibandronate—osteoporosis	0.000107	0.000356	CcSEcCtD
Sunitinib—Asthenia—Risedronate—osteoporosis	0.000106	0.000354	CcSEcCtD
Sunitinib—Cough—Estradiol—osteoporosis	0.000106	0.000353	CcSEcCtD
Sunitinib—Pain—Conjugated Estrogens—osteoporosis	0.000106	0.000353	CcSEcCtD
Sunitinib—Constipation—Conjugated Estrogens—osteoporosis	0.000106	0.000353	CcSEcCtD
Sunitinib—Gastrointestinal pain—Zoledronate—osteoporosis	0.000105	0.000351	CcSEcCtD
Sunitinib—Hypertension—Estradiol—osteoporosis	0.000105	0.00035	CcSEcCtD
Sunitinib—Pruritus—Risedronate—osteoporosis	0.000105	0.000349	CcSEcCtD
Sunitinib—Nausea—Calcitriol—osteoporosis	0.000105	0.000348	CcSEcCtD
Sunitinib—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000104	0.000347	CcSEcCtD
Sunitinib—Hypersensitivity—Pamidronate—osteoporosis	0.000104	0.000346	CcSEcCtD
Sunitinib—Chest pain—Estradiol—osteoporosis	0.000104	0.000345	CcSEcCtD
Sunitinib—Myalgia—Estradiol—osteoporosis	0.000104	0.000345	CcSEcCtD
Sunitinib—Arthralgia—Estradiol—osteoporosis	0.000104	0.000345	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000103	0.000342	CcSEcCtD
Sunitinib—Body temperature increased—Zoledronate—osteoporosis	0.000102	0.000339	CcSEcCtD
Sunitinib—Abdominal pain—Zoledronate—osteoporosis	0.000102	0.000339	CcSEcCtD
Sunitinib—Diarrhoea—Risedronate—osteoporosis	0.000101	0.000338	CcSEcCtD
Sunitinib—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000101	0.000338	CcSEcCtD
Sunitinib—Dry mouth—Estradiol—osteoporosis	0.000101	0.000337	CcSEcCtD
Sunitinib—Asthenia—Pamidronate—osteoporosis	0.000101	0.000337	CcSEcCtD
Sunitinib—ABCB1—bone marrow—osteoporosis	0.000101	0.00092	CbGeAlD
Sunitinib—Dizziness—Ethinyl Estradiol—osteoporosis	0.000101	0.000335	CcSEcCtD
Sunitinib—Pruritus—Pamidronate—osteoporosis	9.97e-05	0.000332	CcSEcCtD
Sunitinib—Oedema—Estradiol—osteoporosis	9.92e-05	0.00033	CcSEcCtD
Sunitinib—Infection—Estradiol—osteoporosis	9.86e-05	0.000328	CcSEcCtD
Sunitinib—Dizziness—Risedronate—osteoporosis	9.81e-05	0.000327	CcSEcCtD
Sunitinib—Abdominal pain—Conjugated Estrogens—osteoporosis	9.8e-05	0.000326	CcSEcCtD
Sunitinib—Body temperature increased—Conjugated Estrogens—osteoporosis	9.8e-05	0.000326	CcSEcCtD
Sunitinib—Shock—Estradiol—osteoporosis	9.76e-05	0.000325	CcSEcCtD
Sunitinib—Nervous system disorder—Estradiol—osteoporosis	9.73e-05	0.000324	CcSEcCtD
Sunitinib—Vomiting—Ethinyl Estradiol—osteoporosis	9.67e-05	0.000322	CcSEcCtD
Sunitinib—Diarrhoea—Pamidronate—osteoporosis	9.65e-05	0.000321	CcSEcCtD
Sunitinib—Skin disorder—Estradiol—osteoporosis	9.64e-05	0.000321	CcSEcCtD
Sunitinib—Rash—Ethinyl Estradiol—osteoporosis	9.59e-05	0.000319	CcSEcCtD
Sunitinib—Dermatitis—Ethinyl Estradiol—osteoporosis	9.58e-05	0.000319	CcSEcCtD
Sunitinib—CHEK2—Levonorgestrel—Ethinyl Estradiol—osteoporosis	9.55e-05	0.0174	CbGdCrCtD
Sunitinib—Headache—Ethinyl Estradiol—osteoporosis	9.53e-05	0.000317	CcSEcCtD
Sunitinib—Hypersensitivity—Zoledronate—osteoporosis	9.49e-05	0.000316	CcSEcCtD
Sunitinib—Vomiting—Risedronate—osteoporosis	9.43e-05	0.000314	CcSEcCtD
Sunitinib—Rash—Risedronate—osteoporosis	9.35e-05	0.000311	CcSEcCtD
Sunitinib—Dermatitis—Risedronate—osteoporosis	9.34e-05	0.000311	CcSEcCtD
Sunitinib—Dizziness—Pamidronate—osteoporosis	9.32e-05	0.00031	CcSEcCtD
Sunitinib—Headache—Risedronate—osteoporosis	9.29e-05	0.000309	CcSEcCtD
Sunitinib—Asthenia—Zoledronate—osteoporosis	9.24e-05	0.000308	CcSEcCtD
Sunitinib—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.13e-05	0.000304	CcSEcCtD
Sunitinib—Pruritus—Zoledronate—osteoporosis	9.11e-05	0.000303	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Estradiol—osteoporosis	9.04e-05	0.000301	CcSEcCtD
Sunitinib—Nausea—Ethinyl Estradiol—osteoporosis	9.03e-05	0.000301	CcSEcCtD
Sunitinib—Insomnia—Estradiol—osteoporosis	8.97e-05	0.000299	CcSEcCtD
Sunitinib—Vomiting—Pamidronate—osteoporosis	8.96e-05	0.000298	CcSEcCtD
Sunitinib—Paraesthesia—Estradiol—osteoporosis	8.91e-05	0.000297	CcSEcCtD
Sunitinib—Asthenia—Conjugated Estrogens—osteoporosis	8.9e-05	0.000296	CcSEcCtD
Sunitinib—Rash—Pamidronate—osteoporosis	8.89e-05	0.000296	CcSEcCtD
Sunitinib—Dermatitis—Pamidronate—osteoporosis	8.88e-05	0.000296	CcSEcCtD
Sunitinib—Dyspnoea—Estradiol—osteoporosis	8.85e-05	0.000295	CcSEcCtD
Sunitinib—Headache—Pamidronate—osteoporosis	8.83e-05	0.000294	CcSEcCtD
Sunitinib—Diarrhoea—Zoledronate—osteoporosis	8.81e-05	0.000293	CcSEcCtD
Sunitinib—Nausea—Risedronate—osteoporosis	8.81e-05	0.000293	CcSEcCtD
Sunitinib—Pruritus—Conjugated Estrogens—osteoporosis	8.77e-05	0.000292	CcSEcCtD
Sunitinib—Dyspepsia—Estradiol—osteoporosis	8.73e-05	0.000291	CcSEcCtD
Sunitinib—Decreased appetite—Estradiol—osteoporosis	8.63e-05	0.000287	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Estradiol—osteoporosis	8.57e-05	0.000285	CcSEcCtD
Sunitinib—Fatigue—Estradiol—osteoporosis	8.56e-05	0.000285	CcSEcCtD
Sunitinib—Dizziness—Zoledronate—osteoporosis	8.51e-05	0.000284	CcSEcCtD
Sunitinib—Pain—Estradiol—osteoporosis	8.49e-05	0.000283	CcSEcCtD
Sunitinib—Constipation—Estradiol—osteoporosis	8.49e-05	0.000283	CcSEcCtD
Sunitinib—Diarrhoea—Conjugated Estrogens—osteoporosis	8.48e-05	0.000282	CcSEcCtD
Sunitinib—Nausea—Pamidronate—osteoporosis	8.37e-05	0.000279	CcSEcCtD
Sunitinib—Dizziness—Conjugated Estrogens—osteoporosis	8.2e-05	0.000273	CcSEcCtD
Sunitinib—Vomiting—Zoledronate—osteoporosis	8.19e-05	0.000273	CcSEcCtD
Sunitinib—Rash—Zoledronate—osteoporosis	8.12e-05	0.00027	CcSEcCtD
Sunitinib—Gastrointestinal pain—Estradiol—osteoporosis	8.11e-05	0.00027	CcSEcCtD
Sunitinib—Dermatitis—Zoledronate—osteoporosis	8.11e-05	0.00027	CcSEcCtD
Sunitinib—Headache—Zoledronate—osteoporosis	8.07e-05	0.000269	CcSEcCtD
Sunitinib—Vomiting—Conjugated Estrogens—osteoporosis	7.88e-05	0.000263	CcSEcCtD
Sunitinib—Abdominal pain—Estradiol—osteoporosis	7.84e-05	0.000261	CcSEcCtD
Sunitinib—Body temperature increased—Estradiol—osteoporosis	7.84e-05	0.000261	CcSEcCtD
Sunitinib—Rash—Conjugated Estrogens—osteoporosis	7.82e-05	0.00026	CcSEcCtD
Sunitinib—Dermatitis—Conjugated Estrogens—osteoporosis	7.81e-05	0.00026	CcSEcCtD
Sunitinib—Headache—Conjugated Estrogens—osteoporosis	7.77e-05	0.000259	CcSEcCtD
Sunitinib—Nausea—Zoledronate—osteoporosis	7.65e-05	0.000255	CcSEcCtD
Sunitinib—Nausea—Conjugated Estrogens—osteoporosis	7.36e-05	0.000245	CcSEcCtD
Sunitinib—Hypersensitivity—Estradiol—osteoporosis	7.31e-05	0.000243	CcSEcCtD
Sunitinib—Asthenia—Estradiol—osteoporosis	7.12e-05	0.000237	CcSEcCtD
Sunitinib—Pruritus—Estradiol—osteoporosis	7.02e-05	0.000234	CcSEcCtD
Sunitinib—Diarrhoea—Estradiol—osteoporosis	6.79e-05	0.000226	CcSEcCtD
Sunitinib—Dizziness—Estradiol—osteoporosis	6.56e-05	0.000219	CcSEcCtD
Sunitinib—Vomiting—Estradiol—osteoporosis	6.31e-05	0.00021	CcSEcCtD
Sunitinib—Rash—Estradiol—osteoporosis	6.26e-05	0.000208	CcSEcCtD
Sunitinib—Dermatitis—Estradiol—osteoporosis	6.25e-05	0.000208	CcSEcCtD
Sunitinib—Headache—Estradiol—osteoporosis	6.22e-05	0.000207	CcSEcCtD
Sunitinib—Nausea—Estradiol—osteoporosis	5.89e-05	0.000196	CcSEcCtD
Sunitinib—FGFR1—Immune System—IL1B—osteoporosis	2.39e-06	7.47e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6R—osteoporosis	2.39e-06	7.46e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1B—osteoporosis	2.38e-06	7.45e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SPP1—osteoporosis	2.37e-06	7.41e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ADCY5—osteoporosis	2.37e-06	7.39e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IGF1—osteoporosis	2.36e-06	7.38e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SPP1—osteoporosis	2.36e-06	7.37e-06	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—osteoporosis	2.36e-06	7.37e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GPX1—osteoporosis	2.36e-06	7.36e-06	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—osteoporosis	2.36e-06	7.36e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—OXCT1—osteoporosis	2.36e-06	7.36e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CA2—osteoporosis	2.36e-06	7.36e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IRS1—osteoporosis	2.35e-06	7.34e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ADCY5—osteoporosis	2.35e-06	7.32e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—osteoporosis	2.34e-06	7.32e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GPX1—osteoporosis	2.34e-06	7.3e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ADCY5—osteoporosis	2.33e-06	7.28e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—POMC—osteoporosis	2.33e-06	7.28e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IRS1—osteoporosis	2.32e-06	7.25e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—ESR1—osteoporosis	2.32e-06	7.23e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—ESR1—osteoporosis	2.31e-06	7.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MGLL—osteoporosis	2.3e-06	7.17e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—osteoporosis	2.3e-06	7.17e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IRS2—osteoporosis	2.28e-06	7.12e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—osteoporosis	2.28e-06	7.12e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IRS1—osteoporosis	2.28e-06	7.12e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IRS1—osteoporosis	2.28e-06	7.12e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6R—osteoporosis	2.27e-06	7.1e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—POMC—osteoporosis	2.26e-06	7.07e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SPP1—osteoporosis	2.26e-06	7.04e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IGF1—osteoporosis	2.24e-06	7e-06	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—osteoporosis	2.24e-06	7e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—POMC—osteoporosis	2.24e-06	6.98e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—LEP—osteoporosis	2.23e-06	6.97e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IRS2—osteoporosis	2.23e-06	6.95e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—osteoporosis	2.22e-06	6.93e-06	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—osteoporosis	2.22e-06	6.92e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—osteoporosis	2.21e-06	6.91e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6R—osteoporosis	2.21e-06	6.89e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—osteoporosis	2.2e-06	6.87e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—POMC—osteoporosis	2.2e-06	6.85e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—POMC—osteoporosis	2.2e-06	6.85e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6R—osteoporosis	2.18e-06	6.81e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—LEP—osteoporosis	2.18e-06	6.8e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IGF1—osteoporosis	2.18e-06	6.8e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—osteoporosis	2.18e-06	6.8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IRS1—osteoporosis	2.16e-06	6.75e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—osteoporosis	2.16e-06	6.74e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IRS1—osteoporosis	2.16e-06	6.74e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—osteoporosis	2.16e-06	6.74e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IGF1—osteoporosis	2.15e-06	6.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—osteoporosis	2.15e-06	6.71e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IRS2—osteoporosis	2.15e-06	6.7e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6R—osteoporosis	2.14e-06	6.69e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6R—osteoporosis	2.14e-06	6.69e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IRS2—osteoporosis	2.13e-06	6.67e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ESR1—osteoporosis	2.13e-06	6.66e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MYC—osteoporosis	2.12e-06	6.63e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TGFB1—osteoporosis	2.12e-06	6.62e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IGF1—osteoporosis	2.11e-06	6.59e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IGF1—osteoporosis	2.11e-06	6.59e-06	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—osteoporosis	2.1e-06	6.57e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—LEP—osteoporosis	2.1e-06	6.56e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—osteoporosis	2.1e-06	6.54e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—LEP—osteoporosis	2.09e-06	6.52e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—POMC—osteoporosis	2.08e-06	6.5e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—osteoporosis	2.08e-06	6.5e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ESR1—osteoporosis	2.08e-06	6.5e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—POMC—osteoporosis	2.08e-06	6.49e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.07e-06	6.48e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—osteoporosis	2.07e-06	6.48e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—osteoporosis	2.07e-06	6.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—osteoporosis	2.07e-06	6.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—osteoporosis	2.06e-06	6.43e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—osteoporosis	2.05e-06	6.41e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—osteoporosis	2.05e-06	6.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IRS2—osteoporosis	2.04e-06	6.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6R—osteoporosis	2.03e-06	6.35e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6R—osteoporosis	2.03e-06	6.33e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ESR1—osteoporosis	2.01e-06	6.26e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IGF1—osteoporosis	2e-06	6.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IGF1—osteoporosis	2e-06	6.24e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—LEP—osteoporosis	2e-06	6.23e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ESR1—osteoporosis	1.99e-06	6.23e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MYC—osteoporosis	1.99e-06	6.22e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IRS1—osteoporosis	1.99e-06	6.22e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TGFB1—osteoporosis	1.99e-06	6.21e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—osteoporosis	1.98e-06	6.18e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—osteoporosis	1.98e-06	6.17e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MYC—osteoporosis	1.97e-06	6.17e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TGFB1—osteoporosis	1.97e-06	6.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—osteoporosis	1.97e-06	6.15e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ENO1—osteoporosis	1.96e-06	6.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—IDH2—osteoporosis	1.95e-06	6.1e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IRS1—osteoporosis	1.94e-06	6.07e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PSMA2—osteoporosis	1.93e-06	6.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PSMA5—osteoporosis	1.93e-06	6.03e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—osteoporosis	1.92e-06	5.99e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ESR1—osteoporosis	1.91e-06	5.95e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IRS1—osteoporosis	1.87e-06	5.85e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—osteoporosis	1.87e-06	5.85e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6R—osteoporosis	1.87e-06	5.84e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—MYC—osteoporosis	1.87e-06	5.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IRS1—osteoporosis	1.86e-06	5.82e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—osteoporosis	1.86e-06	5.82e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—osteoporosis	1.86e-06	5.82e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—osteoporosis	1.85e-06	5.77e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1—osteoporosis	1.85e-06	5.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—MYC—osteoporosis	1.85e-06	5.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—osteoporosis	1.84e-06	5.75e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.84e-06	5.73e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6R—osteoporosis	1.83e-06	5.7e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—MYC—osteoporosis	1.81e-06	5.66e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MYC—osteoporosis	1.81e-06	5.65e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—osteoporosis	1.81e-06	5.64e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—osteoporosis	1.81e-06	5.64e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—osteoporosis	1.8e-06	5.63e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1—osteoporosis	1.8e-06	5.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—osteoporosis	1.79e-06	5.6e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ACP5—osteoporosis	1.79e-06	5.58e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IRS1—osteoporosis	1.78e-06	5.56e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6R—osteoporosis	1.76e-06	5.5e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6R—osteoporosis	1.75e-06	5.47e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MYC—osteoporosis	1.74e-06	5.44e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—osteoporosis	1.74e-06	5.43e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—osteoporosis	1.74e-06	5.43e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1—osteoporosis	1.74e-06	5.42e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MYC—osteoporosis	1.73e-06	5.41e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—osteoporosis	1.73e-06	5.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—osteoporosis	1.73e-06	5.39e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—osteoporosis	1.73e-06	5.39e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—MYC—osteoporosis	1.72e-06	5.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—osteoporosis	1.72e-06	5.36e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—MYC—osteoporosis	1.72e-06	5.36e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—osteoporosis	1.72e-06	5.36e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—osteoporosis	1.71e-06	5.34e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ADCY5—osteoporosis	1.7e-06	5.29e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GPX1—osteoporosis	1.69e-06	5.28e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MYC—osteoporosis	1.68e-06	5.24e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MYC—osteoporosis	1.68e-06	5.24e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—osteoporosis	1.68e-06	5.23e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—osteoporosis	1.68e-06	5.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6R—osteoporosis	1.67e-06	5.22e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—osteoporosis	1.66e-06	5.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TPI1—osteoporosis	1.66e-06	5.19e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—osteoporosis	1.65e-06	5.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—osteoporosis	1.65e-06	5.15e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MYC—osteoporosis	1.64e-06	5.11e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—osteoporosis	1.63e-06	5.1e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—osteoporosis	1.6e-06	4.99e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MYC—osteoporosis	1.58e-06	4.94e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—osteoporosis	1.58e-06	4.93e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—osteoporosis	1.57e-06	4.89e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP19A1—osteoporosis	1.57e-06	4.89e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—P4HB—osteoporosis	1.56e-06	4.88e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—osteoporosis	1.56e-06	4.87e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MYC—osteoporosis	1.55e-06	4.83e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—osteoporosis	1.54e-06	4.81e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GAPDH—osteoporosis	1.53e-06	4.79e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—osteoporosis	1.52e-06	4.75e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—osteoporosis	1.5e-06	4.69e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—osteoporosis	1.5e-06	4.68e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—RAP1A—osteoporosis	1.49e-06	4.66e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MYC—osteoporosis	1.49e-06	4.65e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—osteoporosis	1.49e-06	4.64e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—osteoporosis	1.48e-06	4.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MYC—osteoporosis	1.48e-06	4.63e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—osteoporosis	1.48e-06	4.61e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—osteoporosis	1.48e-06	4.61e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—osteoporosis	1.48e-06	4.61e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—osteoporosis	1.42e-06	4.44e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—osteoporosis	1.42e-06	4.43e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—osteoporosis	1.42e-06	4.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—osteoporosis	1.41e-06	4.41e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—osteoporosis	1.41e-06	4.41e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—osteoporosis	1.4e-06	4.39e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—osteoporosis	1.4e-06	4.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—osteoporosis	1.4e-06	4.36e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—osteoporosis	1.39e-06	4.33e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—osteoporosis	1.36e-06	4.25e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—osteoporosis	1.36e-06	4.25e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—osteoporosis	1.35e-06	4.21e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—osteoporosis	1.34e-06	4.2e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—osteoporosis	1.32e-06	4.12e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—osteoporosis	1.31e-06	4.09e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—osteoporosis	1.31e-06	4.08e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—osteoporosis	1.31e-06	4.08e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—osteoporosis	1.3e-06	4.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—osteoporosis	1.29e-06	4.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—osteoporosis	1.29e-06	4.03e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—osteoporosis	1.29e-06	4.03e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—osteoporosis	1.29e-06	4.03e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—osteoporosis	1.29e-06	4.02e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADCY5—osteoporosis	1.28e-06	3.99e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—osteoporosis	1.27e-06	3.98e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—osteoporosis	1.27e-06	3.96e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—osteoporosis	1.27e-06	3.96e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—osteoporosis	1.27e-06	3.95e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—osteoporosis	1.27e-06	3.95e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—osteoporosis	1.26e-06	3.94e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—osteoporosis	1.26e-06	3.94e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—osteoporosis	1.26e-06	3.94e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—osteoporosis	1.26e-06	3.93e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—osteoporosis	1.25e-06	3.89e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—osteoporosis	1.23e-06	3.84e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—osteoporosis	1.21e-06	3.79e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ENO1—osteoporosis	1.21e-06	3.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—osteoporosis	1.21e-06	3.77e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—osteoporosis	1.2e-06	3.76e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—osteoporosis	1.2e-06	3.75e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—osteoporosis	1.2e-06	3.75e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—osteoporosis	1.2e-06	3.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—osteoporosis	1.19e-06	3.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMA5—osteoporosis	1.19e-06	3.71e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMA2—osteoporosis	1.19e-06	3.71e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—osteoporosis	1.18e-06	3.67e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—osteoporosis	1.16e-06	3.63e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—osteoporosis	1.15e-06	3.6e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—osteoporosis	1.12e-06	3.5e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—osteoporosis	1.11e-06	3.48e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—osteoporosis	1.11e-06	3.46e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—osteoporosis	1.11e-06	3.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—osteoporosis	1.08e-06	3.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—osteoporosis	1.08e-06	3.37e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—osteoporosis	1.07e-06	3.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—osteoporosis	1.06e-06	3.32e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—osteoporosis	1.04e-06	3.26e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—osteoporosis	1.04e-06	3.25e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—osteoporosis	1.04e-06	3.24e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—osteoporosis	1.03e-06	3.23e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—osteoporosis	1.01e-06	3.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—osteoporosis	9.91e-07	3.1e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—osteoporosis	9.89e-07	3.09e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—osteoporosis	9.83e-07	3.07e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—osteoporosis	9.71e-07	3.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.65e-07	3.01e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—osteoporosis	9.54e-07	2.98e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—osteoporosis	9.54e-07	2.98e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—osteoporosis	9.41e-07	2.94e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—osteoporosis	9.05e-07	2.83e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—osteoporosis	9.03e-07	2.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—osteoporosis	8.34e-07	2.6e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—osteoporosis	8.13e-07	2.54e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADCY5—osteoporosis	7.88e-07	2.46e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—osteoporosis	7.85e-07	2.45e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—osteoporosis	7.84e-07	2.45e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—osteoporosis	7.8e-07	2.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—osteoporosis	7.45e-07	2.33e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—osteoporosis	7.25e-07	2.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—osteoporosis	5.8e-07	1.81e-06	CbGpPWpGaD
